Maimon Yossi

CIK 00013851152 companiesCARMIEL, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001385115

Recent Transactions

49 trades

Disposition to Issuer
Old Ayala, Inc
Stock Option (right to buy)
2023-01-19−9,460→ 0 total
Disposition to Issuer
Old Ayala, Inc
Common Stock
2023-01-19−69,872→ 0 total
Disposition to Issuer
Old Ayala, Inc
Stock Option (right to buy)
2023-01-19−70,500→ 0 total
Disposition to Issuer
Old Ayala, Inc
Stock Option (right to buy)
2023-01-19−19,170→ 0 total
Disposition to Issuer
Old Ayala, Inc
Stock Option (right to buy)
2023-01-19−31,950→ 0 total
Award
Old Ayala, Inc
Common Stock
2022-05-16+50,000→ 69,872 total
Award
Old Ayala, Inc
Stock Option
2022-01-03+31,950→ 31,950 total
Award
Old Ayala, Inc
Stock Option
2021-01-04+19,170→ 19,170 total
Award
Old Ayala, Inc
Common Stock
2021-01-04+8,520→ 19,872 total
Award
Old Ayala, Inc
Common Stock
2020-05-07+11,352→ 11,352 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2018-09-13+700,000→ 700,000 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2015-12-14$0.78/sh+10,000→ 10,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2015-03-23+250,000→ 250,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-07-16+185,000→ 185,000 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$0.97/sh+75,964→ 75,964 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$7.13/sh−125,964→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−50,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$2.65/sh+50,000→ 125,964 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−75,964→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-07$0.97/sh+77,769→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-07$9.67/sh−70,000→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-10-07$9.73/sh−7,769→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-10-07−77,769→ 75,964 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-07$8.16/sh−31,500→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-09-07−70,000→ 153,733 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-07$0.97/sh+70,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-09-03$8.00/sh−38,500→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-02-25+130,000→ 130,000 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-16$9.21/sh−17,698→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-16$0.97/sh+167,698→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-10-16−167,698→ 223,733 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-16$9.35/sh−40,300→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-15$9.50/sh−109,700→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$4.95/sh−12,217→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$0.97/sh+62,217→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-07-07−62,217→ 391,431 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-07$5.01/sh−10,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-06$5.13/sh−40,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$0.97/sh+40,348→ 40,348 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$4.00/sh−30,000→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-18$3.79/sh−10,348→ 30,000 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-05-18+40,348→ 453,648 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-13$2.23/sh−7,500→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-13$2.16/sh−17,910→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-03-13−39,800→ 493,996 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-13$0.97/sh+39,800→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-12$2.22/sh−32,241→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-11$2.30/sh−8,849→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-02-25+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100

View on SEC.gov